scholarly article | Q13442814 |
P50 | author | Valentina Pastore | Q83534632 |
P2093 | author name string | Fabio Bartoli | |
P2860 | cites work | TGF-beta and epithelial-to-mesenchymal transitions | Q29616456 |
Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings | Q30885853 | ||
Epidermal growth factor and monocyte chemotactic peptide-1 expression in reflux nephropathy | Q30949539 | ||
Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury | Q33668655 | ||
Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells | Q34267140 | ||
Role of epidermal growth factor receptor in acute and chronic kidney injury | Q36224457 | ||
Current surgical management of vesicoureteral reflux | Q37316640 | ||
Vesicoureteric reflux and renal injury | Q37711619 | ||
Potential physiologic roles for epidermal growth factor in the kidney | Q37738853 | ||
Vesicoureteric reflux and reflux nephropathy: from mouse models to childhood disease | Q38185597 | ||
Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction in adult rats | Q39376751 | ||
Progression after release of obstructive nephropathy | Q39419546 | ||
Incidence of post-pyelonephritic renal scarring: a meta-analysis of the dimercapto-succinic acid literature | Q40404714 | ||
Serum and urine interleukin-6 and transforming growth factor-beta1 in young infants with pyelonephritis. | Q40457136 | ||
Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. | Q41019598 | ||
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study | Q42518413 | ||
Urinary levels of interleukin-6 and interleukin-8 in patients with vesicoureteral reflux and renal parenchymal scar | Q43190426 | ||
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy | Q43695465 | ||
Dextranomer/hyaluronic Acid copolymer implant for vesicoureteral reflux: role of myofibroblast differentiation. | Q50611194 | ||
Urinary beta 2-microglobulin as a marker for vesicoureteral reflux. | Q50995510 | ||
Is urinary kidney injury molecule-1 a noninvasive marker for renal scarring in children with vesicoureteral reflux? | Q54066193 | ||
Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator | Q59067829 | ||
Increased expression of TGF-beta1 but not of its receptors contributes to human obstructive nephropathy | Q73265450 | ||
Urinary epidermal growth factor in different renal conditions in children | Q74353082 | ||
Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? | Q78580447 | ||
Urinary epidermal growth factor, monocyte chemotactic protein-1, and β2-microglobulin in children with ureteropelvic junction obstruction | Q83534634 | ||
Clinical course of 735 children and adolescents with primary vesicoureteral reflux | Q83989276 | ||
Urine IL-8 concentrations in infectious and non-infectious urinary tract conditions | Q84169964 | ||
[Vesico-ureteral reflux, endoscopic management] | Q87193108 | ||
P433 | issue | 3 | |
P304 | page(s) | 549-555 | |
P577 | publication date | 2017-02-10 | |
P1433 | published in | International Brazilian Journal of Urology | Q26841933 |
P1476 | title | Urinary excretion of EGF and MCP-1 in children with vesicoureteral reflux | |
P478 | volume | 43 |
Q99557635 | Role of Urinary Transforming Growth Factor Beta-B1 and Monocyte Chemotactic Protein-1 as Prognostic Biomarkers in Posterior Urethral Valve | cites work | P2860 |
Search more.